A Universal Tumor-Specific Promoter for Cancer Gene Therapy
An artificial double tandem tumor-specific promoter based on survivin and human telomerase reverse transcriptase gene promoters was constructed. Studies in in vitro and ex vivo therapeutic systems showed that the designed promoter exhibits a high activity in tumor cells, which is comparable to the activity of the CMV constitutive promoter.
Unable to display preview. Download preview PDF.
- 3.Farokhimanesh, S., Rahbarizadeh, F., Rasaee, M.J., Kamali, A., and Mashkani, B., Hybrid promoters directed tbid gene expression to breast cancer cells by transcriptional targeting, Biotech. Prog., 2010, vol. 26, pp. 505–511.Google Scholar
- 5.Alekseenko, I.V., Pleshkan, V.V., Kopantzev, E.P., Stukacheva, E.A., Chernov, I.P., Vinogradova, T.V., and Sverdlov, E.D., Activity of the upstream component of tandem tert/survivin promoters depends on features of the downstream component, PLoS One, 2012, vol. 7, e46474.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Mori, K., Iwata, J., Miyazaki, M., Osada, H., Tange, Y., Yamamoto, T., Aiko, Y., Tamura, M., and Shiroishi, T., Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells, Neurol. Med. Chir. (Tokyo), 2010, vol. 50, pp. 545–553.CrossRefGoogle Scholar
- 10.Azatian, A., Yu, H., Dai, W., Schneiders, F.I., Botelho, N.K., and Lord, R.V., Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas, J. Gastrointest. Surg., 2009, vol. 13, pp. 1044–1051.CrossRefPubMedGoogle Scholar